337 related articles for article (PubMed ID: 34453222)
1. Prevention of Atherosclerotic Cardiovascular Disease in Children with Familial Hypercholesterolemia.
Peterson AL; McNeal CJ; Wilson DP
Curr Atheroscler Rep; 2021 Aug; 23(10):64. PubMed ID: 34453222
[TBL] [Abstract][Full Text] [Related]
2. Cascade screening and treatment of children with familial hypercholesterolemia in Turkey.
Kose E; Kose M; Ozturk SI; Ozcan E; Onay H; Ozkan B
J Pediatr Endocrinol Metab; 2020 Aug; 33(10):1251-1256. PubMed ID: 32829317
[TBL] [Abstract][Full Text] [Related]
3. Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Lozano P; Henrikson NB; Dunn J; Morrison CC; Nguyen M; Blasi PR; Anderson ML; Whitlock EP
JAMA; 2016 Aug; 316(6):645-55. PubMed ID: 27532919
[TBL] [Abstract][Full Text] [Related]
4. Misperceptions and management of LDL-cholesterol in secondary prevention of patients with familial hypercholesterolemia in cardiology practice: Real-life evidence from the EPHESUS registry.
Kayıkcioglu M; Başaran Ö; Doğan V; Mert KU; Mert GÖ; Özdemir İH; Rencüzoğulları İ; Karadeniz FÖ; Tekinalp M; Aşkın L; Demirelli S; Gencer E; Bekar L; Aktaş M; Resulzade MM; Kalçık M; Aksan G; Cinier G; Akay KH; Pekel N; Utku Şenol ; Demir V; İnci S; Derviş E; Özlek B; Özlek E; Çelik O; Çil C; Biteker M
J Clin Lipidol; 2023; 17(6):732-742. PubMed ID: 38072583
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials).
McCullough PA; Ballantyne CM; Sanganalmath SK; Langslet G; Baum SJ; Shah PK; Koren A; Mandel J; Davidson MH
Am J Cardiol; 2018 Apr; 121(8):940-948. PubMed ID: 29472008
[TBL] [Abstract][Full Text] [Related]
6. Familial hypercholesterolemia: Review of diagnosis, screening, and treatment.
Turgeon RD; Barry AR; Pearson GJ
Can Fam Physician; 2016 Jan; 62(1):32-7. PubMed ID: 26796832
[TBL] [Abstract][Full Text] [Related]
7. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia.
Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2632-2640. PubMed ID: 34433300
[TBL] [Abstract][Full Text] [Related]
8. My Approach to the Patient With Familial Hypercholesterolemia.
Safarova MS; Kullo IJ
Mayo Clin Proc; 2016 Jun; 91(6):770-86. PubMed ID: 27261867
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal treatment patterns among US patients with atherosclerotic cardiovascular disease or familial hypercholesterolemia initiating lipid-lowering pharmacotherapy.
Burke JP; Simpson RJ; Paoli CJ; McPheeters JT; Gandra SR
J Clin Lipidol; 2016; 10(6):1470-1480.e3. PubMed ID: 27919365
[TBL] [Abstract][Full Text] [Related]
10. Current Approach to the Diagnosis and Treatment of Heterozygote and Homozygous FH Children and Adolescents.
Cohen H; Stefanutti C;
Curr Atheroscler Rep; 2021 May; 23(6):30. PubMed ID: 33963467
[TBL] [Abstract][Full Text] [Related]
11. The Knowns and Unknowns of Contemporary Statin Therapy for Familial Hypercholesterolemia.
Pang J; Chan DC; Watts GF
Curr Atheroscler Rep; 2020 Sep; 22(11):64. PubMed ID: 32870376
[TBL] [Abstract][Full Text] [Related]
12. The effects of 3-year statin therapy and the achievement of LDL cholesterol target values in familial hypercholesterolemia patients: An experience from Serbia.
Lalić K; Rajković N; Popović L; Lukač SS; Stošić L; Rasulić I; Lalić NM
Atherosclerosis; 2018 Oct; 277():298-303. PubMed ID: 30270062
[TBL] [Abstract][Full Text] [Related]
13. Sex differences in the perception of cardiovascular risk in familial hypercholesterolemia.
Alshibani B; Iatan I; Guerin A; Ruel I; Cermakova L; Ramanakumar AV; Pilote L; Coutinho T; Brunham LR; Genest J
J Clin Lipidol; 2024; 18(1):e97-e104. PubMed ID: 37926591
[TBL] [Abstract][Full Text] [Related]
14. Women Living with Familial Hypercholesterolemia: Challenges and Considerations Surrounding Their Care.
Balla S; Ekpo EP; Wilemon KA; Knowles JW; Rodriguez F
Curr Atheroscler Rep; 2020 Aug; 22(10):60. PubMed ID: 32816232
[TBL] [Abstract][Full Text] [Related]
15. How to implement clinical guidelines to optimise familial hypercholesterolaemia diagnosis and treatment.
Farnier M; Civeira F; Descamps O;
Atheroscler Suppl; 2017 Apr; 26():25-35. PubMed ID: 28434482
[TBL] [Abstract][Full Text] [Related]
16. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk.
Lee S; Akioyamen LE; Aljenedil S; Rivière JB; Ruel I; Genest J
Eur J Prev Cardiol; 2019 Aug; 26(12):1262-1270. PubMed ID: 30755017
[TBL] [Abstract][Full Text] [Related]
17. Familial hypercholesterolemia and its manifestations: Practical considerations for general practitioners.
Anagnostis P; Antza C; Florentin M; Kotsis V
Kardiol Pol; 2023; 81(11):1081-1088. PubMed ID: 37937357
[TBL] [Abstract][Full Text] [Related]
18. Preventing early cardiovascular death in patients with familial hypercholesterolemia.
Repas TB; Tanner JR
J Am Osteopath Assoc; 2014 Feb; 114(2):99-108. PubMed ID: 24481802
[TBL] [Abstract][Full Text] [Related]
19. Dyslipidaemia as a target for atherosclerotic cardiovascular disease prevention in children with type 1 diabetes: lessons learned from familial hypercholesterolaemia.
Corpeleijn WE; de Waal WJ; Schipper HS; Wiegman A
Diabetologia; 2024 Jan; 67(1):19-26. PubMed ID: 38032368
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
